SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 140 filers reported holding SUTRO BIOPHARMA INC in Q1 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $57 | -72.9% | 12,250 | -73.1% | 0.00% | -80.0% |
| Q1 2023 | $210 | -99.9% | 45,540 | +105.2% | 0.01% | -16.7% |
| Q1 2022 | $182,000 | -59.6% | 22,189 | -26.7% | 0.01% | -78.6% |
| Q4 2021 | $450,000 | -30.2% | 30,262 | -11.4% | 0.06% | -34.9% |
| Q3 2021 | $645,000 | +53.9% | 34,152 | +51.5% | 0.09% | -39.0% |
| Q2 2021 | $419,000 | -59.8% | 22,550 | -50.8% | 0.14% | -57.7% |
| Q1 2021 | $1,042,000 | -25.3% | 45,790 | -28.7% | 0.33% | -16.3% |
| Q4 2020 | $1,395,000 | – | 64,250 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
| Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
| Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
| Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
| FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
| BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
| Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
| Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |